Bridgebio Pharma Inc. (BBIO)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Viking Global

Andreas Halvorsen

26,620,991 $1,893,019 5.2%
2.
Perceptive Advisors

Joseph Edelman

6,706,268 $476,883 5.11%
3. 2,265,762 $161,118 3.83%
4. 662,958 $47,143 13.15%
5.
Iridian Asset Management

David Cohen And Harold Levy

544,127 $38,693 0.7%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$62.50 8,000 Officer 300,043 2021-02-17 Filing
$62.50 16,000 Director 21,000 2021-02-17 Filing
$17.00 2,647,100 Large Shareholder 36,900,661 2019-07-01 Filing
$17.00 14,000 Officer 14,000 2019-07-01 Filing
$17.00 7,000 Officer 180,767 2019-07-01 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$60.47 3,450,000 31,060,971 2021-02-17 Filing
$69.94 8,563 Officer 12,568 2020-12-28 Filing
$69.34 10,937 Officer 21,131 2020-12-28 Filing
$65.48 45,473 Officer, Director 45,860 2020-12-21 Filing
$64.81 14,928 Officer, Director 91,333 2020-12-21 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 165,402 $11,761,737 0%
2. 34,510,971 $2,454,075 12.44%
3. 11,179 $794,939 0%
4. 10,960 $779,000 0.11%
5. 6,517,544 $463,464 0.01%
News See All